Ophthalmic Devices Market : Current Analysis and Forecast (2020-2026)
- UNI4109894
- 170 Pages
- November 2020
- Healthcare
Population aging is one of the major factors that is responsible for the increase in the incidence and prevalence of patients suffering from eye defects. Statistics reveal that 65% of those with visual impairment and 82% of those who are blind are over 50 years old. As per the United Nations, Population aging refers to the change in the composition of a population such that there is an increase in the proportion of older persons. Growth in certain regions and countries is decelerating whereas population aging is accelerating. As per WHO lifestyle changes and urbanization - will also dramatically increase the number of people with eye conditions, vision impairment, and blindness in the coming decades. Myopia is one such condition which is a major public health concern in several East Asian countries, where the condition affects 80% to 90% of high school graduates. Ophthalmology and its subspecialties have been at the forefront of medical innovation and have embraced the rapid advances in several technologies, including pharmacology, imaging, data processing, and devices. Technological innovations in ophthalmology provide ophthalmologists with new ways to improve the quality of care. Scientific and technological advances have also opened a wide range of clinical and research opportunities in the field of eye care.
Essilor International S.A., Bausch Health Companies, Ellex Medical Lasers, Second Sight Medical Products, Hoya Corporation, Alcon, Johnson & Johnson, Carl Zeiss Meditec AG, Escalon Medical Corp., Topcon Corporation, Nidek Co., Staar Surgical, Lumenis, Glaukos Corporation, and Vision Care are some of the prominent players operating in the global ophthalmic devices market. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.
Insights Presented in the Report
“Amongst product type, vision care devices segment holds the major share”
Based on product type, the market is fragmented into vision care devices, surgery devices, and diagnostic and monitoring. The vision care devices dominated the market with a share of 79.2% in 2019 and are expected to maintain its dominance during the forecast period owing to the increasing usage of the electronic devices such as mobiles, PCs and laptops which results in the various eye related defects.
“Amongst vision care products, spectacles sub-segment dominated the market in 2019”
The vision care segment is further subdivided into spectacles and contact lenses. Spectacles dominated the market with a share of 81.6% in 2019 and are expected to maintain its dominance during the forecast period owing to the increasing age, which is probably due to the increased need for presbyopic and post-cataract surgery refractive correction. The current use of spectacles also increased with increasing socioeconomic status possibly related to the increased level of education. However, the contact lenses segment is anticipated to witness the highest CAGR during the forecast period (2021-2026).
“Amongst surgery devices segment, cataract surgery devices segment is expected to dominate the market during the analyzed period”
Based on the surgery devices, the market is bifurcated into cataract surgery devices, glaucoma surgery devices, refractive surgery devices, vitreoretinal surgery devices, and other surgery devices. The cataract surgery devices dominated the market with a share of 66.8% in 2019 and are expected to maintain its dominance during the forecast period owing to the most frequent surgical procedure being performed in many developed countries, providing significant, long-term, and cost-effective improvements in the quality of life for patients of all ages. However, glaucoma surgery devices are anticipated to witness the highest CAGR during the analyzed period.
“Amongst ophthalmic diagnostic and monitoring devices type, optical coherence tomography/scanning laser ophthalmoscopy dominated the market in 2019”
Based on the ophthalmic diagnostic and monitoring devices type, the market is segmented into optical coherence tomography/scanning laser ophthalmoscopy, fundus camera, tonometer, perimeter, optical biometry, ophthalmic operating microscopes, slit lamp, autorefractors, and other diagnostic and monitoring devices. In 2019, optical coherence tomography/scanning laser ophthalmoscopy accounted for 18% of market revenue share and dominated the market. The segment is most commonly utilized in the clinic to diagnose retinal diseases. OCT has become essential in ophthalmology, offering a superior resolution of the retina and some of the adjacent tissues for diagnosis and treatment of eye diseases. New OCT modalities have now been assimilated into ophthalmic oncology to help track the status of ocular and periocular tumors through retinal symptoms.
“Amongst disease area, cataract is expected to dominate the market during the analyzed period”
Based on the disease area, the market is fragmented into a cataract, glaucoma, age-related macular degeneration, diabetic retinopathy, and others. In 2019, the cataract accounted for the maximum market share with 28.5% and is expected to be the leading segment of the ophthalmic devices market during the forecast period. According to the latest assessment by WHO, cataract is responsible for approximately 51% of world blindness, which represents about 20 million people. Although cataracts can be surgically removed, barriers exist in many countries that prevent patients to access surgery. However, Diabetic retinopathy is expected to witness the highest CAGR growth during the forecast period 2021-2026.
“Amongst end-users, optical centers dominated the market in 2019”
Based on end-users, the ophthalmic devices market is fragmented optical centers, hospitals, ophthalmic clinics, and ambulatory surgery centers. In 2019, optical centers accounted for 47.2% of market revenue share and dominated the market. However, the ophthalmic clinic segment is anticipated to witness the highest CAGR during the forecast period.
“North America represents one of the largest markets of ophthalmic devices market”
For a better understanding of the market dynamics of the ophthalmic devices market, a detailed analysis was conducted for different regions across the globe including North America (US, Canada, and Rest of North America), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), and Rest of the World has been conducted. North America dominated the market and generated revenue of US$ 10,826.2 million in 2019 owing to the rising prevalence of ocular disorders, growth in the geriatric population, increase in healthcare expenditure, and technological advancements in ophthalmic devices. Approximately 11 million Americans aged 12 years and older could improve their vision through proper refractive correction.
Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry
Customization Options:
The Ophthalmic Devices Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1.1 Market Definition 26
1.2 Objective of the Study 26
1.3 Limitation 26
1.4 Stakeholders 27
1.5 Currency used in the Report 27
1.6 Scope of the Global Ophthalmic Devices Market Study 27
2. RESEARCH METHODOLOGY OR ASSUMPTION 28
2.1 Research Methodology for Global Ophthalmic Devices Market Study 28
2.1.1 Main objective of the Global Ophthalmic Devices Market Study 29
3. INDUSTRY PERFORMANCE 30
4. EXECUTIVE SUMMARY 31
5. CURRENT AND PROJECTED SCENARIO OF THE WORLD'S EYESIGHT 33
5.1 General Overview 33
5.1.1 Key Facts on the state of the world's eyesight 33
5.1.2 Improving the world’s Eyesight; the Goals of Vision 2020 37
6. COVID-19 IMPACT ON OPHTHALMIC SERVICES 38
6.1 General Overview 38
6.2 Case Study: Ophthalmology Lost More Patient Volume Due to COVID-19 Than Any Other Specialty in United States 38
6.3 Case Study: Effect of COVID-19 related lockdown on ophthalmic practice and patient care in India 39
6.4 Conclusion 41
7. MARKET OVERVIEW 42
7.1 Market Introduction 42
7.2 Market Dynamics 43
7.2.1 Market Drivers 43
7.2.1.1 Accelerating Geriatric Population 43
7.2.1.1.1 Some of the Key Facts regarding Ageing and health 44
7.2.1.2 Growing Number of Eye Defects 44
7.2.1.3 Increasing Demand of Minimally Invasive Surgical Procedures 45
7.2.1.4 Increasing Prevalence of Eye Related Diseases Such as Glaucoma, Cataract, and Others 46
7.2.1.5 Technological Advancements in Developed Regions 47
7.2.1.6 Rise in Global Adoption of Contact Lenses and Spectacles 48
7.2.2 Market Restraints 49
7.2.2.1 Complications Associated with Eye Surgeries 49
7.2.2.2 Reimbursement Policies for Ophthalmic Surgical Procedures 50
7.2.2.3 Lack of Awareness and Accessibility to Eye Care in Developing Countries 50
7.2.3 Market Opportunity 51
7.2.3.1 Programs and Initiatives Worldwide to Reduce the Burden of Eye Related Diseases 51
7.2.3.2 Adoption of Intraocular Lens Technology 51
8. REIMBURSEMENT POLICY 55
8.1 General Overview 55
8.1.1 Codes changes in Ophthalmic Surgery in 2020 55
9. LEGAL & REGULATORY FRAMEWORK 57
9.1 General Overview 57
9.2 Pre-clinical studies for contact lens and care solutions approval 58
9.3 China 61
9.4 Australia 62
10. DEMAND AND SUPPLY SIDE ANALYSIS 64
10.1 Demand Side Analysis 64
10.2 Supply Side Analysis 66
10.2.1 Top Product Launches under Ophthalmic Devices 66
10.2.2 Top Partnerships under Ophthalmic Devices 73
10.2.3 Top Mergers & Acquisitions under Ophthalmic Devices 74
10.2.4 Top Business Expansion & Investment under Ophthalmic Devices 78
11. VALUE CHAIN ANALYSIS 81
11.1 Value Chain Analysis 81
12. MARKET INSIGHTS BY PRODUCT 83
12.1 General Overview 83
12.2 Vision Care 84
12.2.1 Spectacles 86
12.2.2 Contact Lens 89
12.3 Surgery Devices 91
12.3.1 Cataract Surgery Devices 92
12.3.2 Glaucoma Surgery Devices 94
12.3.3 Refractive Surgery Devices 96
12.3.4 Vitreoretinal Surgery Devices 98
12.3.5 Other Surgery Devices 101
12.4 Diagnostic and Monitoring Devices 101
12.4.1 Optical Coherence Tomography Scanner 104
12.4.2 Fundus Camera 106
12.4.3 Tonometer 110
12.4.4 Perimeter 112
12.4.5 Optical Biometry 113
12.4.6 Ophthalmic Operating Microscopes 114
12.4.7 Slit Lamp 115
12.4.8 Autorefractors 118
12.4.9 Other Diagnostics & Monitoring Devices 119
13. OPHTHALMIC DEVICES MARKET INSIGHTS, BY DISEASE AREA 121
13.1 General Overview 121
13.1.1 Cataract 123
13.1.2 Glaucoma 124
13.1.3 Age Related Macular Diseases 127
13.1.4 Diabetic Retinopathy 129
13.1.5 Others 130
14. OPHTHALMIC DEVICES MARKET INSIGHTS, BY END USERS 132
14.1 General Overview 132
14.1.1 Hospitals 133
14.1.2 Ophthalmic Clinics 136
14.1.3 Ambulatory Surgery Centers 137
14.1.4 Optical Centers 139
15. MARKET INSIGHTS BY REGION 141
15.1 General Overview 141
15.2 North America Ophthalmic Devices Market 142
15.2.1 North America Ophthalmic Devices Market by Product Type 143
15.2.1.1 North America Ophthalmic Vision Care Devices Market Size, by Product Subtypes 143
15.2.1.2 North America Ophthalmic Surgery Devices Market Size, by Product Subtypes 144
15.2.1.3 North America Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 144
15.2.2 North America Ophthalmic Devices Market Size by Disease Area 145
15.2.3 North America Ophthalmic Devices Market Size by End-Users 146
15.2.4 North America Ophthalmic Devices Market by Country 146
15.2.4.1 United States Ophthalmic Devices Market 147
15.2.4.1.1 US Healthcare Expenditure 149
15.2.4.1.2 United States Ophthalmic Devices Market by Product Type 151
15.2.4.1.3 United States Ophthalmic Vision Care Devices Market, by Product Subtypes 152
15.2.4.1.4 United States Ophthalmic Surgery Devices Market Size, by Product Subtypes 152
15.2.4.1.5 United States Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 153
15.2.4.1.6 United States Ophthalmic Devices Market Size by Disease Area 154
15.2.4.1.7 United States Ophthalmic Devices Market Size by End-Users 154
15.2.4.2 Canada Ophthalmic Devices Market 155
15.2.4.2.1 Canada Ophthalmic Devices Market by Product Type 157
15.2.4.2.2 Canada Ophthalmic Vision Care Devices Market Size, by Product Subtypes 158
15.2.4.2.3 Canada Ophthalmic Surgery Devices Market Size, by Product Subtypes 158
15.2.4.2.4 Canada Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 159
15.2.4.2.5 Canada Ophthalmic Devices Market Size by Disease Area 160
15.2.4.2.6 Canada Ophthalmic Devices Market Size by End-Users 160
15.2.4.3 Rest of North America Ophthalmic Devices Market 161
15.2.4.3.1 Rest of NA Ophthalmic Devices Market by Product Type 161
15.2.4.3.2 Rest of NA Ophthalmic Vision Care Devices Market Size, by Product Subtypes 162
15.2.4.3.3 Rest of NA Ophthalmic Surgery Devices Market Size, by Product Subtypes 163
15.2.4.3.4 Rest of NA Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 163
15.2.4.3.5 Rest of NA Ophthalmic Devices Market Size by Disease Area 164
15.2.4.3.6 Rest of NA Ophthalmic Devices Market Size by End-Users 165
15.3 Europe Ophthalmic Devices Market 165
15.3.1 Europe Ophthalmic Devices Market by Product Type 166
15.3.1.1 Europe Ophthalmic Vision Care Devices Market Size, by Product Subtypes 166
15.3.1.2 Europe Ophthalmic Surgery Devices Market Size, by Product Subtypes 167
15.3.1.3 Europe Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 167
15.3.2 Europe Ophthalmic Devices Market Size by Disease Area 168
15.3.3 Europe Ophthalmic Devices Market Size by End-Users 169
15.3.4 Europe Ophthalmic Devices Market by Country 169
15.3.4.1 France Ophthalmic Devices Market 170
15.3.4.1.1 France Ophthalmic Devices Market by Product Type 171
15.3.4.1.2 France Ophthalmic Vision Care Devices Market Size, by Product Subtypes 172
15.3.4.1.3 France Ophthalmic Surgery Devices Market Size, by Product Subtypes 172
15.3.4.1.4 France Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 173
15.3.4.1.5 France Ophthalmic Devices Market Size by Disease Area 174
15.3.4.1.6 France Ophthalmic Devices Market Size by End-Users 174
15.3.4.2 Germany Ophthalmic Devices Market 175
15.3.4.2.1 Germany Ophthalmic Devices Market by Product Type 176
15.3.4.2.2 Germany Ophthalmic Vision Care Devices Market Size, by Product Subtypes 176
15.3.4.2.3 Germany Ophthalmic Surgery Devices Market Size, by Product Subtypes 177
15.3.4.2.4 Germany Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 177
15.3.4.2.5 Germany Ophthalmic Devices Market Size by Disease Area 178
15.3.4.2.6 Germany Ophthalmic Devices Market Size by End-Users 179
15.3.4.3 Italy Ophthalmic Devices Market 179
15.3.4.3.1 Key Facts of Healthcare Spending - Italy in 2018, by Region 181
15.3.4.3.2 Italy Ophthalmic Devices Market by Product Type 183
15.3.4.3.3 Italy Ophthalmic Vision Care Devices Market Size, by Product Subtypes 183
15.3.4.3.4 Italy Ophthalmic Surgery Devices Market Size, by Product Subtypes 184
15.3.4.3.5 Italy Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 184
15.3.4.3.6 Italy Ophthalmic Devices Market Size by Disease Area 185
15.3.4.3.7 Italy Ophthalmic Devices Market Size by End-Users 186
15.3.4.4 Spain Ophthalmic Devices Market 186
15.3.4.4.1 Spain Healthcare Expenditure Statistics 187
15.3.4.4.2 Spain Ophthalmic Devices Market by Product Type 189
15.3.4.4.3 Spain Ophthalmic Vision Care Devices Market Size, by Product Subtypes 189
15.3.4.4.4 Spain Ophthalmic Surgery Devices Market Size, by Product Subtypes 190
15.3.4.4.5 Spain Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 190
15.3.4.4.6 Spain Ophthalmic Devices Market Size by Disease Area 191
15.3.4.4.7 Spain Ophthalmic Devices Market Size by End-Users 192
15.3.4.5 United Kingdom Ophthalmic Devices Market 192
15.3.4.5.1 United Kingdom – Healthcare Expenditure 194
15.3.4.5.2 United Kingdom Ophthalmic Devices Market by Product Type 196
15.3.4.5.3 United Kingdom Ophthalmic Vision Care Devices Market Size, by Product Subtypes 197
15.3.4.5.4 United Kingdom Ophthalmic Surgery Devices Market Size, by Product Subtypes 198
15.3.4.5.5 United Kingdom Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 198
15.3.4.5.6 United Kingdom Ophthalmic Devices Market Size by Disease Area 199
15.3.4.5.7 United Kingdom Ophthalmic Devices Market Size by End-Users 200
15.3.4.6 Rest of Europe Ophthalmic Devices Market 200
15.3.4.6.1 Rest of Europe Ophthalmic Devices Market by Product Type 202
15.3.4.6.2 Rest of Europe Ophthalmic Vision Care Devices Market Size, by Product Subtypes 202
15.3.4.6.3 Rest of Europe Ophthalmic Surgery Devices Market Size, by Product Subtypes 203
15.3.4.6.4 Rest of Europe Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 203
15.3.4.6.5 Rest of Europe Ophthalmic Devices Market Size by Disease Area 204
15.3.4.6.6 Rest of Europe Ophthalmic Devices Market Size by End-Users 205
15.4 Asia Pacific Ophthalmic Devices Market 205
15.4.1 Asia-Pacific Ophthalmic Devices Market by Product Type 207
15.4.1.1 Asia-Pacific Ophthalmic Vision Care Devices Market Size, by Product Subtypes 207
15.4.1.2 Asia-Pacific Ophthalmic Surgery Devices Market Size, by Product Subtypes 208
15.4.1.3 Asia-Pacific Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 208
15.4.2 Asia-Pacific Ophthalmic Devices Market Size by Disease Area 209
15.4.3 Asia-Pacific Ophthalmic Devices Market Size by End-Users 210
15.4.4 Asia-Pacific Ophthalmic Devices Market by Country 210
15.4.4.1 Japan Ophthalmic Devices Market 211
15.4.4.1.1 Japan Ophthalmic Devices Market by Product Type 212
15.4.4.1.2 Japan Ophthalmic Vision Care Devices Market Size, by Product Subtypes 212
15.4.4.1.3 Japan Ophthalmic Surgery Devices Market Size, by Product Subtypes 213
15.4.4.1.4 Japan Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 213
15.4.4.1.5 Japan Ophthalmic Devices Market Size by Disease Area 214
15.4.4.1.6 Japan Ophthalmic Devices Market Size by End-Users 215
15.4.4.2 China Ophthalmic Devices Market 215
15.4.4.2.1 China Ophthalmic Devices Market by Product Type 217
15.4.4.2.2 China Ophthalmic Vision Care Devices Market Size, by Product Subtypes 217
15.4.4.2.3 China Ophthalmic Surgery Devices Market Size, by Product Subtypes 218
15.4.4.2.4 China Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 218
15.4.4.2.5 China Ophthalmic Devices Market Size by Disease Area 219
15.4.4.2.6 China Ophthalmic Devices Market Size by End-Users 220
15.4.4.3 South Korea Ophthalmic Devices Market 220
15.4.4.3.1 South Korea Ophthalmic Devices Market by Product Type 221
15.4.4.3.2 South Korea Ophthalmic Vision Care Devices Market Size, by Product Subtypes 222
15.4.4.3.3 South Korea Ophthalmic Surgery Devices Market Size, by Product Subtypes 222
15.4.4.3.4 South Korea Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 223
15.4.4.3.5 South Korea Ophthalmic Devices Market Size by Disease Area 224
15.4.4.3.6 South Korea Ophthalmic Devices Market Size by End-Users 224
15.4.4.4 India Ophthalmic Devices Market 225
15.4.4.4.1 India Ophthalmic Devices Market by Product Type 227
15.4.4.4.2 India Ophthalmic Vision Care Devices Market Size, by Product Subtypes 228
15.4.4.4.3 India Ophthalmic Surgery Devices Market Size, by Product Subtypes 228
15.4.4.4.4 India Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 229
15.4.4.4.5 India Ophthalmic Devices Market Size by Disease Area 230
15.4.4.4.6 India Ophthalmic Devices Market Size by End-Users 230
15.4.4.5 Rest of Asia-Pacific Ophthalmic Devices Market 231
15.4.4.5.1 Rest of Asia-Pacific Ophthalmic Devices Market by Product Type 234
15.4.4.5.2 Rest of Asia-Pacific Ophthalmic Vision Care Devices Market Size, by Product Subtypes 234
15.4.4.5.3 Rest of Asia-Pacific Ophthalmic Surgery Devices Market Size, by Product Subtypes 235
15.4.4.5.4 Rest of Asia-Pacific Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 235
15.4.4.5.5 Rest of Asia-Pacific Ophthalmic Devices Market Size by Disease Area 236
15.4.4.5.6 Rest of Asia-Pacific Ophthalmic Devices Market Size by End-Users 237
15.5 Rest of World Ophthalmic Devices Market 237
15.5.1 Rest of World Ophthalmic Devices Market by Product Type 239
15.5.1.1 Rest of World Ophthalmic Vision Care Devices Market Size, by Product Subtypes 240
15.5.1.2 Rest of World Ophthalmic Surgery Devices Market Size, by Product Subtypes 240
15.5.1.3 Rest of World Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes 241
15.5.2 Rest of World Ophthalmic Devices Market Size by Disease Area 242
15.5.3 Rest of World Ophthalmic Devices Market Size by End-Users 242
16. COMPETITIVE SCENARIO 243
16.1 Porter’s Five forces analysis 243
16.1.1 Bargaining power of the Supplier 243
16.1.2 Bargaining power of Buyer 244
16.1.3 Industry Rivalry 244
16.1.4 Availability of Substitute 244
16.1.5 Threat of New Entrants 244
16.2 Market Share Analysis, by Company 2019 245
16.2.1 Market Share of Key Players in Ophthalmic Devices, 2019 245
17. TOP COMPANY PROFILES 249
17.1 Essilor International S.A. 249
17.1.1 Key Facts 249
17.1.2 Business Description 249
17.1.3 Key Product/Services Offerings 249
17.1.4 Growth Strategy 250
17.1.5 SWOT Analysis 251
17.1.6 Key Financials 251
17.1.6.1 Revenue Split, by Region and Segment 252
17.1.7 Recent Developments 253
17.1.7.1 Business Expansions Essilor International 253
17.2 Bausch Health Companies Inc. 254
17.2.1 Key Facts 254
17.2.2 Business Description 254
17.2.3 Key Product/Services Offerings 255
17.2.4 Growth Strategy 255
17.2.5 SWOT Analysis 257
17.2.6 Key Financials 258
17.2.6.1 Revenue Split, by Region and Segment 259
17.2.7 Recent Developments 260
17.2.7.1 Product Launches 260
17.2.7.2 Partnerships 261
17.2.7.3 Business Expansions and Investment 261
17.2.7.4 Mergers and Acquisitions 262
17.3 Ellex Medical Lasers 263
17.3.1 Key Facts 263
17.3.2 Business Description 264
17.3.3 Key Product/Services Offerings 264
17.3.4 Growth Strategy 264
17.3.5 SWOT Analysis 265
17.3.6 Key Financials 266
17.3.6.1 Revenue Split, by Region and Segment 267
17.3.7 Recent Developments 267
17.3.7.1 Product Launches 267
17.3.7.2 Merger and Acquisition 267
17.4 Escalon Medical Corp 268
17.4.1 Key Facts 268
17.4.2 Business Description 268
17.4.3 Key Product/Services Offerings 269
17.4.4 Growth Strategy 269
17.4.5 SWOT Analysis 271
17.4.6 Key Financials 271
17.4.6.1 Revenue Split, by Region and Segment 272
17.4.7 Recent Developments 273
17.4.7.1 Product Launches 273
17.5 Second Sight Medical Products Inc. 274
17.5.1 Key Facts 274
17.5.2 Business Description 274
17.5.3 Key Product/Services Offerings 275
17.5.4 Growth Strategy 275
17.5.5 SWOT Analysis 276
17.5.6 Key Financials 277
17.5.6.1 Revenue Split, by Region and Segment 278
17.5.7 Recent Developments 278
17.5.7.1 Product Launches 278
17.5.7.2 Partnerships 279
17.5.7.3 Business Expansions and Investment 279
17.6 Hoya Corporation 280
17.6.1 Key Facts 280
17.6.2 Business Description 280
17.6.3 Key Product/Services Offerings 281
17.6.4 Growth Strategy 281
17.6.5 SWOT Analysis 283
17.6.6 Key Financials 284
17.6.6.1 Revenue Split, by Region and Segment 285
17.6.7 Recent Developments 285
17.6.7.1 Product Launches 285
17.6.7.2 Partnerships 286
17.6.7.3 Business Expansions and Investment 286
17.6.7.4 Mergers and Acquisitions 287
17.7 Alcon, Inc 288
17.7.1 Key Facts 288
17.7.2 Business Description 288
17.7.1 Key Product/Services Offerings 289
17.7.2 Growth Strategy 290
17.7.3 SWOT Analysis 291
17.7.4 Alcon, Inc Key Financials 292
17.7.4.1 Revenue Split, by Region and Segment 293
17.7.5 Recent Developments 293
17.7.5.1 Product Launches 293
17.7.5.2 Mergers and Acquisitions 294
17.8 Johnson & Johnson 295
17.8.1 Key Facts 295
17.8.2 Business Description 295
17.8.3 Key Product/Services Offerings 296
17.8.4 SWOT Analysis 297
17.8.5 Key Financials 297
17.8.5.1 Revenue Split 298
17.8.6 Recent Developments 299
17.8.6.1 Business Expansions and Investment 299
17.9 Carl Zeiss Meditec Ag 300
17.9.1 Key Facts 300
17.9.2 Business Description 300
17.9.3 Key Product/Services Offerings 300
17.9.4 Growth Strategy 301
17.9.5 SWOT Analysis 302
17.9.6 Key Financials 303
17.9.6.1 Revenue Split, by Region and Segment 304
17.9.7 Recent Developments 304
17.9.7.1 Product Launches 304
17.9.7.2 Partnerships 305
17.9.7.3 Business Expansions and Investment 306
17.9.7.4 Mergers and Acquisitions 306
17.10 Topcon Corporation 308
17.10.1 Key Facts 308
17.10.2 Ownership Structure 308
17.10.3 Business Description 308
17.10.4 Key Product/Services Offerings 309
17.10.5 Growth Strategy 310
17.10.6 SWOT Analysis 311
17.10.7 Key Financials 311
17.10.7.1 Revenue Split, by Region and Segment 312
17.10.8 Recent Developments 313
17.10.8.1 Product Launches 313
17.10.8.2 Partnerships 313
17.10.8.3 Business Expansions and Investment 313
17.10.8.4 Mergers and Acquisitions 314
17.11 NIDEK CO., LTD 315
17.11.1 Key Facts 315
17.11.2 Business Description 315
17.11.3 Key Product/Services Offerings 316
17.11.4 Growth Strategy 316
17.11.5 SWOT Analysis 317
17.11.6 Key Financials 317
17.11.6.1 Revenue Split, by Region and Segment 318
17.11.7 Recent Developments 318
17.11.7.1 Product Launches 318
17.11.7.2 Business Expansions and Investment 320
17.12 STAAR Surgical 321
17.12.1 Key Facts 321
17.12.2 Business Description 321
17.12.3 Key Product/Services Offerings 322
17.12.4 Growth Strategy 322
17.12.5 SWOT Analysis 323
17.12.6 Key Financials 324
17.12.7 Key Metrics 325
17.12.7.1 Revenue Split, by Region and Segment 326
17.12.7.2 Financial Overview of Staar Surgical 326
17.12.8 Recent Developments 326
17.12.8.1 Partnerships 326
17.12.8.2 Mergers and Acquisitions 327
17.13 Lumenis 328
17.13.1 Key Facts 328
17.13.2 Business Description 328
17.13.3 Growth Strategy 330
17.13.4 Overview of Lumenis 330
17.13.5 Recent Developments 331
17.13.5.1 Product Launches 331
17.13.5.2 Mergers and Acquisitions 331
17.14 Glaukos Corporation, CA 332
17.14.1 Key Facts 332
17.14.2 Business Description 332
17.14.3 Key Product/Services Offerings 333
17.14.4 Growth Strategy 334
17.14.5 SWOT Analysis 335
17.14.6 Key Financials 336
17.14.6.1 Revenue Split, by Region and Segment 337
17.14.6.2 Financial Overview of Glaukos Corporation 337
17.14.7 Recent Developments 338
17.14.7.1 Partnerships 338
17.14.7.2 Business Expansions and Investment 338
17.14.7.3 Mergers and Acquisitions 339
17.15 VisionCare, Inc. 340
17.15.1 Key Facts 340
17.15.2 Business Description 340
17.15.3 Key Product/Services Offerings 340
17.15.4 Vision Care Inc Growth Strategy 340
17.15.5 SWOT Analysis 341
17.15.6 Recent Developments 341
17.15.6.1 Business Expansions and Investment 341
TABLE 2 Minimally Invasive Glaucoma Surgeries (MIGS) Devices and Techniques 46
TABLE 3 Estimated Prevalence of Myopia for Each Global Burden of Disease Region, 2000-2050 (in percentage) 48
TABLE 4 Multifocal Intraocular Lenses 52
TABLE 5 2020 Reimbursement Changes ((* MAC priced); US$) 56
TABLE 6 Reimbursement Changes, 2019 56
TABLE 7 Key ISO Standards specific to Contact Lenses 59
TABLE 8 Comparison FDA and EU Commission in Regulations of Medical Devices, contact lenses and their care solutions 60
TABLE 9 The TGA medical device classification system 62
TABLE 10 Key Facts on Prevalence of Common Eye Disorder 65
TABLE 11 Top Product Launches under Ophthalmic Devices 66
TABLE 12 Top Partnerships under Ophthalmic Devices 73
TABLE 13 Top Mergers & Acquisitions under Ophthalmic Devices 74
TABLE 14 Top Business Expansion & Investment under Ophthalmic Devices 78
TABLE 15 Future impact of innovative technologies across the care journey 82
TABLE 16 Trends in the Business Portion of Practices 90
TABLE 17 Minimally Invasive Glaucoma Surgery Devices 95
TABLE 18 Refractive Products and Equipment 97
TABLE 19 Global Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product, 2019-26 (US$ Mn) 104
TABLE 20 Commercially available OCTA Systems 105
TABLE 21 Technical Specifications of Fundus Cameras Under Different Categories 107
TABLE 22 Illumination and Observation Techniques for Slit Lamp Biomicroscopy of the Anterior Eye 115
TABLE 23 Filters available on most Slit Lamp Biomicroscopes 118
TABLE 24 Current MIGS device: Clinical outcomes (% IOP reduction and change in number of medications) 126
TABLE 25 Molecules attached to monomeric elastin-like recombinamers and their mechanism of action 128
TABLE 26 Comparison of Portable Telemedical Devices for Diabetic Retinopathy Screening 129
TABLE 27 Ophthalmology Services in Hospital 133
TABLE 28 Variation in Site of Cataract Surgery in Communities With at Least 100 Cataract Surgeries Performed 138
TABLE 29 North America Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Type, 2019-26 (US$ Mn) 144
TABLE 30 Leading Sites of New Cancer Cases and Deaths – 2020 Estimates 149
TABLE 31 United States Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Type, 2019-26 (US$ Mn) 153
TABLE 32 Number of providers in eye health and vision care and percent change, 2010–2015 157
TABLE 33 Canada Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Type, 2019-26 (US$ Mn) 159
TABLE 34 Rest of NA Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Type, 2019-26 (US$ Mn) 163
TABLE 35 Europe Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes, 2019-26 (US$ Mn) 167
TABLE 36 France - Government Health Expenditure 171
TABLE 37 France Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes, 2019-26 (US$ Mn) 173
TABLE 38 Germany Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes, 2019-26 (US$ Mn) 177
TABLE 39 Italy Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes, 2019-26 (US$ Mn) 184
TABLE 40 Prevalence of Myopia, Hyperopia and Astigmatism Stratified by Age 186
TABLE 41 Spain Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product, 2019-26 (US$ Mn) 190
TABLE 42 Health Expenditure by Country, Expenditure as % GVA 196
TABLE 43 United Kingdom Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product, 2019-26 (US$ Mn) 198
TABLE 44 Rest of Europe Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product, 2019-26 (US$ Mn) 203
TABLE 45 Asia-Pacific Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product, 2019-26 (US$ Mn) 208
TABLE 46 Japan Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product, 2019-26 (US$ Mn) 213
TABLE 47 Estimated Sex-Specific Prevalence of any Cataract and ARC in China, by Age Group 216
TABLE 48 China Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes, 2019-26 (US$ Mn) 218
TABLE 49 South Korea Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes, 2019-26 (US$ Mn) 223
TABLE 50 Costs of the Eye Surgery based on the type of surgery required in various countries (US$) 226
TABLE 51 India Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes, 2019-26 (US$ Mn) 229
TABLE 52 Savings to Society from Private Cataract Surgeries, by payer, 2017-18, US$ 232
TABLE 53 Estimated cataract separations by age and gender, 2017-18 233
TABLE 54 Estimated cataract surgery separations by state/territory, 2017-18 233
TABLE 55 Rest of Asia-Pacific Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes, 2019-26 (US$ Mn) 235
TABLE 56 Rest of World Ophthalmic Diagnostic and Monitoring Devices Market Size, by Product Subtypes, 2019-26 (US$ Mn) 241
TABLE 57 Essilor International S.A Key Facts 249
TABLE 58 Product Segmentation of Essilor International 249
TABLE 59 Essilor International Growth Strategy 250
TABLE 60 Bausch Health Companies Inc. Key Facts 254
TABLE 61 Bausch Health Companies Inc. Ownership Structure 254
TABLE 62 Product segmentation of Bausch Health Companies Inc. 255
TABLE 63 Bausch Health Companies Inc. Growth Strategy 255
TABLE 64 Bausch Health Companies Inc. Product Launches 260
TABLE 65 Bausch Health Companies Inc. Partnerships 261
TABLE 66 Bausch Health Companies Inc. Business Expansions, Investment and Divestitures 261
TABLE 67 Bausch Health Companies Inc. Mergers and Acquisitions 262
TABLE 68 Ellex Medical Lasers Key Facts 263
TABLE 69 Ellex Medical Lasers, Ownership Structure 263
TABLE 70 Product segmentation of Ellex Medical Lasers 264
TABLE 71 Ellex Medical Lasers Growth Strategy 264
TABLE 72 Ellex Medical Lasers Product Launches 267
TABLE 73 Ellex Medical Lasers Merger and Acquisition 267
TABLE 74 Escalon Medical Corp Key Facts 268
TABLE 75 Escalon Medical Corp Ownership Structure 268
TABLE 76 Product segmentation of Escalon Medical Corp. 269
TABLE 77 Escalon Medical Corp Growth Strategy 269
TABLE 78 Escalon Medical Corp, Product Launches 273
TABLE 79 Second Sight Medical Products Inc. Key Facts 274
TABLE 80 Second Sight Medical Products Inc. Ownership Structure 274
TABLE 81 Product segmentation of Second Sight Medical Products Inc. 275
TABLE 82 Second Sight Medical Products Inc. Growth Strategy 275
TABLE 83 Second Sight Medical Products Inc. Product Launches 278
TABLE 84 Second Sight Medical Products Inc. Partnerships 279
TABLE 85 Second Sight Medical Products Inc. Business Expansions and Investment 279
TABLE 86 Key Facts Hoya Corporation 280
TABLE 87 Product segmentation of Hoya Corporation 281
TABLE 88 Hoya Corporation Growth Strategy 281
TABLE 89 Hoya Corporation Product Launches 285
TABLE 90 Hoya Corporation Partnerships 286
TABLE 91 Hoya Corporation Business Expansions, Investment and Divestitures 286
TABLE 92 Hoya Corporation Mergers and Acquisitions 287
TABLE 93 Alcon, Inc Key Facts 288
TABLE 94 Alcon, Inc Ownership Structure 288
TABLE 95 Alcon, Inc. Product/Services Offerings 289
TABLE 96 Alcon, Inc Growth Strategy 290
TABLE 97 Alcon, Inc Product Launches 293
TABLE 98 Alcon, Inc Mergers and Acquisitions 294
TABLE 99 Johnson & Johnson Key Facts 295
TABLE 100 Product segmentation of Johnson & Johnson 296
TABLE 101 Johnson & Johnson Growth Strategy 296
TABLE 102 Johnson & Johnson Vision Business Expansions, Investment and Divestitures 299
TABLE 103 Carl Zeiss Meditec Ag Key Facts 300
TABLE 104 Product segmentation of Carl Zeiss Meditec Ag 300
TABLE 105 Carl Zeiss Meditec Ag Growth Strategy 301
TABLE 106 Carl Zeiss Meditec Ag Product Launches 304
TABLE 107 Carl Zeiss Meditec Ag Partnerships 305
TABLE 108 Carl Zeiss Meditec AG Business Expansions, Investment and Divestitures 306
TABLE 109 Carl Zeiss Meditec Ag Mergers and Acquisitions 306
TABLE 110 Topcon Corporation, Key Facts 308
TABLE 111 Topcon Corporation, Ownership Structure 308
TABLE 112 Topcon Corporation, Tokyo 309
TABLE 113 Topcon Corporation, Growth Strategy 310
TABLE 114 Topcon Corporation, Product Launches 313
TABLE 115 Topcon Corporation, Partnerships 313
TABLE 116 Topcon Corporation, Business Expansions, Investment and Divestitures 313
TABLE 117 Topcon Corporation, Mergers and Acquisitions 314
TABLE 118 NIDEK CO., LTD Key Facts 315
TABLE 119 Product segmentation of NIDEK CO., LTD 316
TABLE 120 NIDEK CO., LTD Growth Strategy 316
TABLE 121 NIDEK CO., LTD Product Launches 318
TABLE 122 NIDEK CO., LTD. Business Expansions, Investment and Divestitures 320
TABLE 123 STAAR Surgical Key Facts 321
TABLE 124 Staar Surgical Ownership Structure 321
TABLE 125 Product segmentation of STAAR Surgical 322
TABLE 126 STAAR Surgical Partnerships 326
TABLE 127 STAAR Surgical Mergers and Acquisitions 327
TABLE 128 Lumenis North America, Inc. Key Facts 328
TABLE 129 Product segmentation of Lumenis 329
TABLE 130 Lumenis, North America, Inc. Product Launches 331
TABLE 131 Lumenis North America, Inc. Mergers and Acquisitions 331
TABLE 132 Glaukos Corporation, CA Key Facts 332
TABLE 133 Glaukos Corporation, CA Ownership Structure 332
TABLE 134 Glaukos Corporation, Key Product/Services Offerings 333
TABLE 135 Glaukos Corporation, Partnerships 338
TABLE 136 Glaukos Corporation, Business Expansions, Investment and Divestitures 338
TABLE 137 Glaukos Corporation, Mergers and Acquisitions 339
TABLE 138 VisionCare, Inc. Key Facts 340
TABLE 139 Product Offerings of VisionCare, Inc. 340
TABLE 140 Product Offerings of VisionCare, Inc. 340
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
